i-manager Publications

Enhanced Urease-Driven Nanobots for Radionuclide-Based Bladder Cancer Therapy

S. Mohammed Sahil*, S. Atheena Milagi Pandian**, Rashika Murugan***

*-*** Atheenapandian Private Limited, India.

Periodicity:January - March'2024
DOI : https://doi.org/10.26634/jms.11.4.20821

Abstract

Bladder cancer treatment with intravenous medication delivery has reasonable survival rates but modest therapeutic efficacy. Taking advantage of their superior diffusion and mixing capacities in urine compared to traditional pharmaceuticals or passive nanoparticles, self-propelled nanoparticles, also known as nanobots, have been proposed as a solution to the latter issue. Nonetheless, nothing is known about how well nanobots can translate into bladder cancer treatments. Here, urease-powered, radiolabelled mesoporous silica-based nanobots were evaluated in an orthotopic animal model of bladder cancer. Both in vivo and ex vivo findings showed increased accumulation of nanobots at the tumor location; positron emission tomography in vivo showed an eight-fold increase. The ex vivo tumor penetration by nanobots was validated by label-free optical contrast based on polarization-dependent scattered light-sheet microscopy of cleared bladders. Intravesically treatment was given to tumor-bearing mice. About 90% less tumor size was observed when radio-iodinated nanobots were used for radionuclide therapy, establishing nanobots as effective delivery nanosystems for bladder cancer treatment.

Keywords

Nanorobots, Nanobots, Treatment, Cancer Therapy, Bladder Cancer, Orthotopic.

How to Cite this Article?

Sahil, S. M., Pandian, S. A. M., and Murugan, R. (2024). Enhanced Urease-Driven Nanobots for Radionuclide-Based Bladder Cancer Therapy. i-manager’s Journal on Material Science, 11(4), 8-14. https://doi.org/10.26634/jms.11.4.20821

References

[1]. Aghakhani, A., Pena-Francesch, A., Bozuyuk, U., Cetin, H., Wrede, P., & Sitti, M. (2022). High shear rate propulsion of acoustic microrobots in complex biological fluids. Science Advances, 8(10), eabm5126.

[2]. Akolpoglu, M. B., Alapan, Y., Dogan, N. O., Baltaci, S. F., Yasa, O., Aybar Tural, G., & Sitti, M. (2022). Magnetically steerable bacterial microrobots moving in 3D biological matrices for stimuli-responsive cargo delivery. Science Advances, 8(28), eabo6163.

[3]. Arqué, X., Patiño, T., & Sánchez, S. (2022). Enzyme- powered micro-and nano-motors: Key parameters for an application-oriented design. Chemical Science, 13(32), 9128-9146.

[4]. Aziz, A., Holthof, J., Meyer, S., Schmidt, O. G., & Medina Sánchez, M. (2021). Dual ultrasound and photoacoustic tracking of magnetically driven micromotors: From in vitro to in vivo. Advanced Healthcare Materials, 10(22), 2101077.

[5]. Choi, H., Cho, S. H., & Hahn, S. K. (2020). Urease- powered polydopamine nanomotors for intravesical therapy of bladder diseases. American Chemical Society (ACS), 14(6), 6683-6692.

[6]. De Corato, M., Arqué, X., Patiño, T., Arroyo, M., Sánchez, S., & Pagonabarraga, I. (2020). Self-propulsion of active colloids via ion release: Theory and experiments. Physical Review Letters, 124(10), 108001.

[7]. Gao, C., Wang, Y., Ye, Z., Lin, Z., Ma, X., & He, Q. (2021) . Biomedical micro/nanomotors: From overcoming biological barriers to in vivo imaging. Advanced Materials, 33(6), 2000512.

[8]. Hennrich, U., & Eder, M. (2022). [177Lu] Lu-PSMA-617 (PluvictoTM): The first FDA-approved radiotherapeutical for treatment of prostate cancer. Pharmaceuticals, 15(10), 1292.

[9]. Hortelao, A. C., Simó, C., Guix, M., Guallar-Garrido, S., Julián, E., Vilela, D., ... & Sánchez, S. (2021). Swarming behavior and in vivo monitoring of enzymatic nanomotors within the bladder. Science Robotics, 6(52), eabd2823.

[10]. Liu, C. G., Fu, C. P., Shi, Y. H., Zhong, J., Tang, H. X., Zhang, J. T., ... & Chen, A. Z. (2022). Dual-responsive nanomotors for deep tumor penetration and subcellular arrangement. Materials & Design, 222, 111039.

[11]. Meyer, R. K., Williams, S. J., & Lee, T. Y. (2020). Mycobacterium bovis infection of a femorofemoral by pass graft following intravesical bacillus Calmette–Guérin (BCG) immunotherapy. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 19, 100152.

[12]. Sun, Z., Wang, T., Wang, J., Xu, J., Shen, T., Zhang, T., ... & Hou, Y. (2023). Self-propelled Janus nanocatalytic robots guided by magnetic resonance imaging for enhanced tumor penetration and therapy. Journal of the American Chemical Society, 145(20), 11019-11032.

[13]. Urso, L., Nieri, A., Uccelli, L., Castello, A., Artioli, P., Cittanti, C., ... & Bartolomei, M. (2023). Lutathera® orphans: State of the art and future application of radioligand therapy with 177Lu-DOTATATE. Pharmaceutics, 15(4), 1110.

[14]. Venugopalan, P. L., Esteban-Fernandez de Avila, B., Pal, M., Ghosh, A., & Wang, J. (2020). Fantastic voyage of nanomotors into the cell. American Chemical Society (ACS), 14(8), 9423-9439.

[15]. Wan, M., Wang, Q., Li, X., Xu, B., Fang, D., Li, T., ... & Wei, J. (2020). Systematic research and evaluation models of nanomotors for cancer combined therapy. Angewandte Chemie International Edition, 59(34), 14458-14465.

[16]. Xu, D., Hu, J., Pan, X., Sanchez, S., Yan, X., & Ma, X. (2021). Enzyme-powered liquid metal nanobots endowed with multiple biomedical functions. American Chemical Society (ACS), 15(7), 11543-11554.

[17]. Zhang, F., Mundaca Uribe, R., Askarinam, N., Li, Z., Gao, W., Zhang, L., & Wang, J. (2022). Biomembrane functionalized micromotors: Biocompatible active devices for diverse biomedical applications. Advanced Materials, 34(5), 2107177.

[18]. Zheng, S., Wang, Y., Pan, S., Ma, E., Jin, S., Jiao, M., ... & Wang, H. (2021). Biocompatible nanomotors as active diagnostic imaging agents for enhanced magnetic resonance imaging of tumor tissues in vivo. Advanced Functional Materials, 31(24), 2100936.

[19]. Seidl, C. (2020). Targets for therapy of bladder cancer. In Seminars in Nuclear Medicine, 50(2), pp. 162-170. WB Saunders.

[20]. Simó, C., Serra-Casablancas, M., Hortelao, A. C., Di Carlo, V., Guallar-Garrido, S., Plaza-García, S., ... & Sánchez, S. (2024). Urease-powered nanobots for radionuclide bladder cancer therapy. Nature Nanotechnology, 1-11.

[21]. Chinol, M., De Cobelli, O., Trifirò, G., Scardino, E., Bartolomei, M., Verweij, F., ... & Paganelli, G. (2003). Localization of avidin in superficial bladder cancer: a potentially new approach for radionuclide therapy. European Urology, 44(5), 556-559.

	North Americas,UK, Middle East,Europe		India	Rest of world
	USD	EUR	INR	USD-ROW
Pdf	35	35	200	20
Online	35	35	200	15
Pdf & Online	35	35	400	25

Enhanced Urease-Driven Nanobots for Radionuclide-Based Bladder Cancer Therapy

Abstract

Keywords

How to Cite this Article?

References

If you have access to this article please login to view the article or kindly login to purchase the article

Purchase Instant Access

Options for accessing this content: